drugset
drugset / Trial / NCT00936260

Drug Holidays in the Treatment With Alendronate in Postmenopausal Women With Osteoporosis

NCT00936260 ↗

Completed 228 enrolled Ciudad Universitaria, Spain
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the duration of the treatment with alendronate in postmenopausal women with osteoporosis.

Timeline

Start
1998-01
Primary completion
2004-12
Completion
2004-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Alendronic Acid Small molecule — —

Indications

osteoporosis